期刊文献+

下肢恶性肿瘤术后的分离灌注术疗效观察

Isolated lower limb perfusion after soft tissue sarcoma excision
下载PDF
导出
摘要 [目的]探讨下肢恶性肿瘤术后介入性肢体分离灌注术(ILP)的可行性及临床疗效。[方法]2例右下肢恶性纤维组织细胞瘤,1例右下肢脂肪肉瘤,3例均为手术完全切除肿瘤的患者。术后给予患肢动静脉球囊阻断后的为时20 min的分离灌注术。术后3、6、12、18个月分别予患肢MR I检查,腹部超声,胸部CT,血清CEA、CA125、CA199等肿瘤标记物的复查来评价疗效。[结果]3例患者均未出现治疗相关并发症。在治疗及随访期内,所有患者均无肿瘤复发及远处转移的发生。[结论]介入性的ILP是肢体软组织恶性肿瘤术后一种安全有效的预防复发的治疗手段。 【Objective】 To evaluate the clinical effect of interventional isolated lower limb perfusion after soft tissue sarcoma surgical excision.【Methods】 Two right lower limb malignant soft tissue sarcomas and one left lower limb liposarcoma received tumorectomy.All the 3 patients were given 20 min isolated lower limb perfusion after the soft tissue sarcoma excision.The MRI of the lower limb and abdominal ultrasound and thoraxic CT were performed in 3,6,12 and 18 months after the surgery for evaluation of the clinical effect.At the same time,the serum CEA,CA125,CA199 were also used as clinical effect index.【Results】 No complication was observed during the treatment.No recurrence and metastasis were seen during the follow-up.【Conclusion】 Interventional isolated lower limb perfusion after soft tissue sarcoma surgical excision is an effective and safe method for preventing the recurrence.
出处 《大连医科大学学报》 CAS 2010年第5期562-564,共3页 Journal of Dalian Medical University
关键词 下肢 恶性肿瘤 分离灌注术 lower limb malignant tumor isolated perfusion
  • 相关文献

参考文献12

  • 1Creech O,Krementz E,Ryan E,et al.Chemotherapy ofcancer:regional perfusion utilising an extracorporeal circuit[J].Ann Surg,1958,148:616-632.
  • 2Benckhuijsen C,Kroon BB,van Geel AN,et al.Regional perfusion treatment with melphalan for melanoma in a limb:an evaluation of drug kinetics[J].Eur J Surg Oncol 1988,14:157-163.
  • 3Kroon HM,Lin DY,Kam PC,et al.Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma[J].Cancer,2009,115:1932-1940.
  • 4Kroon HM,Moncrieff M,Kam PC,et al.Outcomes following isolated limb infusion for melanoma.A 14-year experience[J].Ann Surg Oncol,2008,15:3003-3013.
  • 5Barbour AP,Thomas J,Suffolk J,et al.Isolated limb infusion for malignant melanoma:predictors of response and outcome[J].Ann Surg Oncol,2009,16:3463-3472.
  • 6Kroon HM,Thompson JF.Isolated limb infusion:a review[J].J Surg Oncol,2009,100(2):169-177.
  • 7Lienard D,Ewalenko P,Delmotte JJ,et al.High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma[J].J Clin Oncol,1992,10:50-62.
  • 8Noorda EM,Vrouenraets BC,Nieweg OE,et al.Repeat isolated limb perfusion with TNFa and melphalan for recurrent limb melanoma after failure of previous perfusion[J].J Cancer Surg,2006,32:318-324.
  • 9Olieman AFT,van Ginkel RJ,Hoekstra HJ,et al.Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor[J].Ann Surg Oncol,1997,4:64-69.
  • 10Klein ES,Walden R,Ben-Ari GY.Peripheral blood flow studies following isolated limb perfusion with cisplatin[J].Reg Cancer Treat,1993,3:137-139.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部